Home
Conditions
Actinomycetales Infections

Clinical trial condition

Actinomycetales Infections

Explore clinical trials studying Actinomycetales Infections. Study availability and eligibility vary by location and protocol.

1,556 public trials 161 recruiting studies

Refine in advanced search Browse all conditions

Actinomycetales Infections trial results

Completed

Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents

NCT01362322

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Santiago, Chile

GSK Investigational Site Monterrey, Nuevo León, Mexico

GSK Investigational Site Estado de México, Mexico

View Trial Details

Completed

A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes

NCT02238405

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
Locations: Indus Hospital Karachi, Pakistan

View Trial Details

Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

NCT00346073

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations: GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

View all 42 locations

View Trial Details

Completed

Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis

NCT01011543

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: CHU St Pierre; pulmonology department Brussels, Belgium

View Trial Details

Completed

Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children

NCT01988857

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Hanoi, Vietnam

View Trial Details

Completed

A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects.

NCT03202693

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations: Covance Clinical Research Unit Madison, Wisconsin, United States

View Trial Details

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

NCT03423030

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations: Division of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults

NCT01755689

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site Santo Domingo, Dominican Republic

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Bangkok, Thailand

View Trial Details

Completed

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

NCT01498419

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Task Applied Science, Karl Bremer Hospital Cape Town, South Africa

University of Cape Town Lung Institute (Pty) Ltd Cape Town, South Africa

KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) Durban, South Africa

CHRU Themba Lethu Clinic Johannesburg, South Africa

View Trial Details

Completed

Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine

NCT03552445

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations: Not specified

View Trial Details

Actinomycetales Infections

Actinomycetales Infections trial results

Related conditions